Keywords: USA, FTC, Patent settlements, "No-authorized generics", Pay-for-delay deals, Antitrus litigation

US FTC submits amicus brief on "no-authorized generic" deals to delay generic competition

Article | 10 October 2012

The US Federal Trade Commission this week filed an amicus brief in the US District Court for the District of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in